TV-MI, stent thrombosis rates were still significantly lower for Orsiro
At 5 years, patients who underwent percutaneous coronary intervention (PCI) with the Orsiro stent showed numerically lower, but not statistically significantly different, rates of target lesion failure (TLF) compared to the Xience stent, according to new BIOFLOW-V trial results.